Cell Inspire Biotechnology

Cell Inspire Biotechnology is a Shenzhen-based private biotech focused on induced pluripotent stem cell (iPSC) technologies, including iPSC line generation, gene editing, directed differentiation, disease models, and off-the-shelf immune cell therapies. The company positions itself as one of China's earliest commercial iPSC companies and has built platform capabilities spanning iPSC production, gene editing, clinical research support, and immunotherapy development. Its therapeutic pipeline is centered on iPSC-derived CAR-NK and related immune-cell programs for oncology and autoimmune disease, with a lead multiple myeloma program reported in preclinical development. In parallel, Cell Inspire markets iPSC products, disease-model cell lines, and GMP-oriented research services for academic and industry customers. The company also highlights neurodegeneration tools such as Alzheimer's disease iPSC screening models and collaborations intended to support translational research and licensing.